Latest Biotech Startup Funding Rounds
Financing for drug discovery, therapeutics and biological technologies, with the development context behind each round.
- Rounds
- 603 All time
- Disclosed funding
- $28.7B 480 disclosed amounts
- Median round
- $17M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| RM Rakuten MedicalCompany profile Develops and commercializes Alluminox platform-based photoimmunotherapy for cancer treatment Develops and commercializes Alluminox platform-based photoimmunotherapy for cancer treatment | $100M | Series FSeries C+ | Biotech | United States | Investors | |
| CH Corsera HealthCompany profile Develops preventive RNAi medicines for cardiovascular disease prediction and prevention Develops preventive RNAi medicines for cardiovascular disease prediction and prevention | $80M | Series A | Biotech, Healthtech | United States | Investors | |
| ST Uses cells as sensors to uncover first-in-class medicines | $200M | Series CSeries C+ | Biotech | United States | Investors | |
| B BiographicaCompany profile Uses AI-driven discovery to develop next-generation crop traits and improve agricultural productivity and resilience Uses AI-driven discovery to develop next-generation crop traits and improve agricultural productivity and resilience | £7M | Undisclosed | Biotech, Agritech | United Kingdom | Investors | |
| M MicroCytoCompany profile Develops microbial engineering and fermentation processes for bio-based ingredients. Develops microbial engineering and fermentation processes for bio-based ingredients. | ~CN¥300M | Equity financingUndisclosed | Biotech | China | Investors | |
| SB Surv BioPharma develops oncolytic virus therapies for cancer. | ¥670M | Series B second closeSeries B | Biotech | Japan | Investors | |
| D DecodeNAtureCompany profile DecodeNAture develops portable DNA analysis tools for species identification in biodiversity monitoring, agriculture and biosecurity. DecodeNAture develops portable DNA analysis tools for species identification in biodiversity monitoring, agriculture and biosecurity. | CHF 100K | EPFL InnograntUndisclosed | Biotech | Switzerland | Investors | |
| LB Laigo BioCompany profile Laigo Bio develops targeted protein degradation therapies for cancer and autoimmune diseases. Laigo Bio develops targeted protein degradation therapies for cancer and autoimmune diseases. | €11.5M | Seed first closeSeed | Biotech | Netherlands | Investors | |
| SB Surv BioPharma develops oncolytic virus therapies for cancer. | ≤¥2.7B | AMED ecosystem programme supportUndisclosed | Biotech | Japan | Investors | |
| CN Coherence NeuroCompany profile Investigational implants and bioelectronic systems for monitoring and treating cancer. Investigational implants and bioelectronic systems for monitoring and treating cancer. | £500K | ARIA opportunity seed research grantUndisclosed | Biotech, Healthtech | United States | Investors Undisclosed |
Active investors in this selection
All investors →Ranked by rounds participated in · All time
- 1RA Capital Management
Delix Therapeutics, Alethio Therapeutics, Estuary Biotherapeutics
27rounds6led - 2Eli Lilly and Company
Oyster Therapeutics, BigHat Biosciences, Circle Pharma, Inc.
16rounds0led - 3Janus Henderson Investors
Star Therapeutics, OMass Therapeutics, Soufflé Therapeutics
16rounds1led - 4ARCH Venture Partners
Soufflé Therapeutics, Encoded Therapeutics Inc., Moonwalk Biosciences
16rounds1led - 5OrbiMed
Dren Bio, Star Therapeutics, Leal Therapeutics
12rounds1led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.